Miller FG, Joffe S.Benefit in phase 1 oncology trials: Therapeutic misconception or reasonable treatment option?Clin Trials. In press.
2.
Weinfurt KP, DePuy V., Castel LD et al. Understanding of an aggregate probability statement by patients who are offered participation in Phase I clinical trials. Cancer2005; 103: 140-47.
3.
Weinfurt KP, Sulmasy DP, Schulman KA, Meropol NJPatient expectations of benefit from phase I clinical trials: linguistic considerations in diagnosing a therapeutic misconception. Theor Med Bioeth2003; 24: 329-44.
4.
Weinfurt KP, Seils DM, Tzeng JP et al. Expectations of benefit in early-phase clinical trials: implications for assessing the adequacy of informed consent. Med Decis Making2008; 28: 575-81.
5.
Weinfurt KPDiscursive versus information-processing perspectives on a bioethical problem: the case of ``unrealistic'' patient expectations. Theory Psychol2004; 14: 191-203.
6.
James W.Pragmatism, Prometheus Books, Amherst, 1907 .
